FDA Approves Spravato Nasal Spray for Treatment-Resistant Depression
Drug is the first and only approved monotherapy for refractory major depressive disorder
Clinical Practice Guidelines Updated for Management of Stroke Rehab
47 recommendations developed in areas relevant to primary care, including transition to community, motor therapy, mental health
Certain Drug Types Associated With Risk for Dementia
Antimicrobials, vaccines, anti-inflammatories linked to reduced risk for Alzheimer disease and dementia; antipsychotics and diabetes drugs tied to higher risk
GLP-1 Receptor Agonists Tied to Risks and Benefits Beyond Weight Loss
Reduced risks seen for neurocognitive, coagulation, cardiometabolic disorders; increased risks seen for GI, arthritic disorders
1999 to 2021 Saw Rise in Methamphetamine-Related Mortality
This trend may be driven by increases in heroin and synthetic opioids coinvolvement
Pandemic Led to Rapid Adoption of Telemental Health for Those With Schizophrenia
Faster diffusion of telemental health care for schizophrenia seen in state-operated versus free-standing mental health agencies
2011 to 2022 Saw Increasing Prevalence of Poor Mental Health
Inequities noted in outcomes by age, sex, and racial and ethnic group
FDA Approves Marketing of Nicotine Pouches
Approval marks first time the agency has approved sale of a nicotine pouch
Integrated Care Boosts Smoking Cessation When Undergoing Lung Cancer Screening
Integrated care involving medication and intensive counseling provides optimal smoking cessation intervention
Binge Drinking in Retirement Tied to More Depressive Symptoms
Overall, retirement associated with higher levels of depression
